Cerebrospinal Fluid Management Devices Market Size, Share Analysis, Strategies, Revenue And Forecasts To 2023

 The data analysts at Market Research Future Reports (MRFR) have analyzed the global cerebrospinal fluid management devices market.

As per the study, the global market for cerebrospinal fluid management is estimated to record a CAGR of 5.34% and holding a value of USD 2,104.66 million by the end of 2027. The increasing prevalence of neurological diseases such as Parkinson’s disease and Alzheimer’s disease is estimated to be the most significant factor driving the global cerebrospinal fluid management market 2020. Further, the increasing case of hydrocephalus and ventriculomegaly is estimated to augment the market size.

ALSO READ :  https://www.medgadget.com/2020/08/cerebrospinal-fluid-management-devices-market-worth-usd-2104-66-million-at-a-cagr-of-5-34-by-2027-says-mrfr.html 

Also, various public and private companies are implementing various innovative technologies in the development of medical devices’ cerebrospinal fluid management. The established key players adopt tactics like these are estimated to grow the cerebrospinal fluid management devices market in the forthcoming period. In addition, the burgeoning technological development in the field of smart devices, along with the usage of AI and IoT, is another pivotal factor augmenting the market. Further, the rise in geriatric population is estimated to augment the market at the global front.

However, lack of expertise and side-effects related to the treatment is projected to obstruct the market growth in the forthcoming period.

Cerebrospinal Fluid Management Devices Market Segmentation

The global cerebrospinal fluid management devices can be segmented on the basis of age group, end-user, product, and region.

On the basis of age group, the global cerebrospinal fluid management can be segmented into pediatric, adult, and geriatric.

On the basis of end-user, global cerebrospinal fluid management can be segmented into ambulatory settings, hospitals, and research and academic institutes.

On the basis of product, the global cerebrospinal fluid management can be segmented into critical care products, shunts & valves, dural sealants, and others.

On the basis of region, the global cerebrospinal fluid management can be segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

Cerebrospinal Fluid Management Devices Market Regional Analysis

The data experts have conducted the regional analysis of the Americas, Europe, Asia-Pacific, and the Middle East & Africa at MRFR. As per the study, the global market is estimated to be dominated by the Americas. The region is excelling due to the presence of established key players. Besides, the region comprises of advanced healthcare infrastructure. Also, increasing awareness is estimated to expand the regional market. Europe is estimated to acquire the second position. The region has been witnessing a rise in chronic illness due to a change in lifestyle. Besides, the increasing support of the government is likely to affect the regional market positively. Also, the presence of established players in the region is likely to affect the market positively.

On the other hand, the APAC is estimated to take the third position. However, the APAC market is estimated to expand at the fastest pace due to the rising purchasing power. Also, increasing research and development is further likely to augment the market. The MEA region is estimated to acquire a substantial portion during the forecast period owing to the increasing R&D and the growing medical tourism. Besides, the increasing contribution of the government is further estimated to propel the regional market.

Cerebrospinal Fluid Management Devices Market Key Players

The renowned players of the global cerebrospinal fluid management devices market are

• Medtronic Plc (Ireland)
• Natus Medical Incorporated (US)
• B. Braun Melsungen AG (Germany)
• Sophia (France)
• IRRAS AB (Sweden)
• Möller Medical GmbH (Germany)
• Argi Grup (Turkey)
• Longeviti (US)
• Integra Lifesciences Corporation (US)

Cerebrospinal Fluid Management Devices Industry News

June 2020: CereVasc, a US medical device company, has raised  USD 43.9 million to help launch first-in-human clinical testing for invasive hydrocephalus procedure.

FOR MORE DETAILS -  https://www.marketresearchfuture.com/reports/cerebrospinal-fluid-management-devices-market-7196  

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Anti-Viral Drugs Market Shares Analysis, Key Development Strategies And Forecasts Till 2023

 Global Anti-viral drugs Market Report 2020, Research Study, Size, Growth, Share and Industry Analysis by application (hepatitis, HIV/AIDS, herpes, influenza and others) and by mechanism of action (nucleotide polymerase inhibitors, reverse transcriptase inhibitors, protease inhibitors and others) – Forecast to 2022

Anti-viral drugs Market Overview:

Global market for anti-viral drugs has been studied by Market Research Future (MRFR) and it revealed a possibility of surpassing worth of USD 62.67 billion by 2022. This growth would take a CAGR of 6.9% during the forecast period of 2015-2022. Various factors and dynamics are at play when it comes to an assessment of the anti-viral drugs market growth. Various factors like demand for drugs against influenza, HIV, etc. hike in investment for research projects, better technological integration across the healthcare sector, reformation in the structure of the emerging nations, and others can boost the global market.

ALSO READ :  https://www.medgadget.com/2020/04/anti-viral-drugs-market-worth-usd-62-67-billion-by-2022-at-a-cagr-of-6-9-quick-drug-development-procedure-to-ensure-growth-of-anti-viral-drugs-industry.html 

Anti-viral drugs Industry News: 

In March 2020, a report disclosed that Fujifilm’s medicine Avigan or favipiravir is showing significant promises in its battle against COVID-19. The medicine is in high demand in several countries as it has cleared two test runs with success. The Anti-viral drugs Market for this medicine is expanding as several countries are trying to get hold of a proper drug to reduce the number of people contracted and the lockdown period. A prolonged lockdown period means heavy financial toll and the market for this medicine can explore this opportunity to expand the business prospect.

Anti-viral drugs Market Segmentation:

The global report covering various details of the anti-viral drugs market has been segmented by MRFR into application and mechanism of action. This segmentation allows a detailed understanding of various market moves that can improve the decision-making process during the formation of strategies.

By application, the global market for anti-viral drugs can be segmented into influenza, HIV/AIDS, herpes, hepatitis, and others. Various pharmaceutical companies are boosting these segmental research initiatives as their primary goal is to develop a proper drug and increase their market presence.

By the mechanism of action, the report encompassing anti-viral drugs market can be segmented into reverse transcriptase inhibitors, protease inhibitors, nucleotide polymerase inhibitors, and others. The growth for each segment would get boosted by the growing intake in the healthcare sector.

Anti-viral drugs Market Regional Analysis:

The Americas would lead with a 30% share of the global Anti-viral drugs Market. This is possible due to the presence of Canada and the US. These two countries are saving a huge amount of their budgetary plan to establish a proper framework for their healthcare sector. The process is also witnessing a huge surge in the participation of pharmaceutical companies who are constantly trying to take an edge in the market to stay ahead of their peers. In Europe, pharmaceutical companies are witnessing a proper influx of funding and growing scope as the research and development centers are delivering positive results. Government investments in several associated sectors are proving to be beneficial for the market.

South Korea, Japan, China, and India are showing significant potentials in taking the market ahead. These countries have a huge market, which is luring in various global players who are expanding their businesses by launching decent measures.

Anti-viral drugs Market Competitive Landscape:

The global market for anti-viral drugs market is witnessing strong growth with the increasing participation from top-class companies like Merck & Co. Inc., Johnson & Johnson, Hoffmann-La Roche Ltd., Astra Zeneca AB, GlaxoSmithKline Plc, Gilead Sciences Inc., Novartis International AG, Abbott Laboratories, Cipla Inc., and others. These companies are banking on developing various structural methods that include mergers, better research and development facilities, increasing opportunities for expansion, hike in investment plans, and others. These companies have been profiled by MRFR and their latest actions have been includes in the report to facilitate improved strategy-making policies.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/anti-viral-drugs-market-2454 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Worldwide Bioinformatics Market Segmentation And Analysis By Recent Trends And Growth Prospects By Regions To 2023

 The global bioinformatics market is likely to grow at a whopping 19.8% CAGR between 2016- 2022, according to the new report by Market Research Future (MRFR). Bioinformatics, simply put, is a combination of biology & information technology that links biological data with the different techniques for distribution, information storage, and analysis for supporting various areas of scientific research, which also includes biomedicine. Bioinformatics utilizes software tools for data mining, data warehousing, data management, database creation, and others. Agriculture bioinformatics, animal bioinformatics, medical bioinformatics, and others are some of its major end users.  

ALSO READ :  https://www.marketwatch.com/press-release/report-the-impact-of-covid-19-on-bioinformatics-market-2020-research-study-global-size-industry-growth-trends-top-company-revenue-2020-07-13?tesla=y 

Various factors are propelling the global bioinformatics market growth. According to the new MRFR report, such factors include improved collaborations between research institutes and companies, increasing initiatives made by private and government organizations, burgeoning demand for protein sequencing and nucleic acid, increasing funds from the government, and growing use of bioinformatics in biomarker development process & drug discovery. Besides, the introduction of the latest technologies, such as cloud computing and nanopore sequencing, is also adding market growth. Besides, the biopharmaceutical innovators are preparing a viable vaccine for the novel coronavirus and are also investing a good amount of funds into the research and development to tackle the COVID-19 pandemic, which is likely to add to the market growth.  

On the contrary, scarcity of skilled personnel for ensuring the right use of bioinformatics tools, lack of integration of various data that is generated through different bioinformatics platforms, shortage of user-friendly tools at affordable prices, and lack of common data formats are factors that may limit the global bioinformatics market growth over the forecast period.  

Bioinformatics Market Competitive Analysis 

Key players profiled in the global bioinformatics market report include Dassault Systèmes, Thermo Fisher Scientific Inc., QIAGEN, Illumina, Inc., and Agilent Technologies. Industry players have incorporated several strategies to create a niche in the market, such as mergers, acquisitions, new product launches, joint ventures, and more. 

Bioinformatics Market Segmentation 

The MRFR report gives an inclusive segmental analysis of the global bioinformatics market report based on application, technology and services, and sector.  

By application, the global bioinformatics market is segmented into metabolomics, proteomics, molecular phylogenetics, transcriptomics, drug design, chemoinformatics, genomics, and others. Of these, the metabolomics segment will lead the market over the forecast period.  

By technology and services, the global bioinformatics market is segmented into sequence manipulation, sequence analysis, data warehousing, and others.  

By sector, the global bioinformatics market is segmented into agriculture bioinformatics, animal bioinformatics, medical bioinformatics, and others. Of these, the medical bioinformatics segment will have a major share in the market over the forecast period. 

Bioinformatics Market Regional Analysis 

Based on the region, the global bioinformatics market report covers the growth opportunities and recent trends across the Americas, Europe, the Asia Pacific (APAC), & the Middle East and Africa. Of these, the Americas will have the lions share in the market over the forecast period. The presence of developed technologies, increasing healthcare expenditures, and the growing biotechnology sector is adding to the global bioinformatics market growth in the region.  

The global bioinformatics market in Europe is predicted to hold the second-largest share over the forecast period followed by the APAC region. Increasing investments by the government to develop human capital, research initiatives, and infrastructure coupled with increasing healthcare expenditure in the biotechnology industry being made in India & China are adding to the global bioinformatics market growth in the region.  

The global bioinformatics market in the MEA is predicted to have the smallest share over the forecast period for the presence of poor economies, especially in the African region. Meanwhile, the Middle East will have a good share in the market for the presence of developed economies such as Qatar, Kuwait, and others.  

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/bioinformatics-market-2265 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

The Regenerative Medicine Market World Leading Key Players Revenue, Share, Analysis And Estimation Till 2022

 Regenerative Medicine Market information, By Material (Synthetic Materials, Genetically Engineered Materials, Pharmaceuticals), By Therapy (Stem Cell Biology, Cellular Therapy, Tissue Engineering), By Application (Cord Blood, Oncology, Urology, Orthopedics, Neurology, Dermatology) – Forecast till 2022 

Regenerative Medicine Market Dynamics

Global Regenerative Medicine Market can attain a rate of close to 25.4% between 2016 and 2022, considered to be the forecast timeframe in the recently launched report by Market Research Future (MRFR).

ALSO READ : https://www.medgadget.com/2020/02/regenerative-medicine-market-size-expected-to-increase-at-a-cagr-25-4-through-2022-global-industry-report-trends-development-pipeline-regional-analysis-top-companies-statistics.html   

Growth Boosters and Key Barriers

The availability of a robust product pipeline in clinical trials coupled with increasing government and private funding that facilitate research can work in favor of the regenerative medicine market. A strong product pipeline indicates the striking potential of the market in the coming years. many of the companies in the market are making sizeable investments in research and development (R&D) for product upgradation by integrating them with the latest technologies. This strategic move helps these companies fulfill all the unmet consumer demands. Besides, the renowned companies are also analyzing and developing pipeline products for cancer, cardiovascular diseases and diabetes, and neurological disorders, given the rising prevalence of these diseases around the world.

The rising number of programs in conjunction with massive investments by private agencies to enhance the development rate of the medical field also fosters market growth. To cite a reference, the National Institutes of Health or NIH is one such agency that backs the scientific research community via NIH Stem Cell Unit, NIH Stem Cell Libraries & Projects, NIH Regenerative Medicine Program, and others.

Likewise, initiatives taken by the industry players to increase the finance for R&D works wonders for the regenerative medicine market. Additionally, a number of vendors are collaborating to solidify their R&D capabilities in an attempt to commercialize creative therapies to cater to a higher number of customers locally or around the world.

Regenerative Medicine Industry Trends

Regenerative medicine is expected to gather significant attention in the healthcare sector, thanks to its rising applications as well as the substantial advancements in areas like stem cells, tissue engineering, drug discovery, nanotechnology, and gene therapy. For instance, 3D printing enjoys more demand compared to scaffold with stem cells in order to restore the structure as well as the functional properties of biological specimens.

Market Segmentation

The market for regenerative medicine has been studied with respect to segments like material, therapy and application.

The materials covered in the report are genetically engineered materials, synthetic materials, biologically derived materials, pharmaceuticals, and others.

The therapy-based segments are tissue engineering cellular therapy, stem cell biology, and others.

The market segments based on the application are oncology, cord blood, orthopedics, urology, dermatology, neurology, orthopedic, cardiovascular, and others.

Regional Outlook

Global market for regenerative medicine market seems to be expanding at a considerable pace and can immense traction in the primary regions of Latin America, Middle East & Africa, North America, Europe, and Asia Pacific (APAC).

MRFR identifies North America as the leading market for regenerative medicine, with the largest share of over 44% in the global market. The North American market is all set to achieve a lucrative growth rate of 22.3% in subsequent years, given the large number of universities and research organizations that are focused on researching a variety of stem cell-based techniques for regenerative apposition, especially in the United States (U.S.) as well as Canada.

Europe has emerged as the second-most profitable market for regenerative medicine and showcases a massive potential of achieving a growth rate of 22.5% in the coming years. Increasing cases of chronic diseases as well as conditions like Parkinson’s disease, diabetes, and Alzheimer’s disease is boosting the demand for regenerative medicines in the region and can help the market size expand substantially over the forecast timeline.

APAC is racing ahead at a rapid pace and can soon achieve the fastest growth rate in the global regenerative medicine market. Infrastructural development along with the modification of facilities in an attempt to speed up stem cell research in emerging countries benefits the market in APAC.

Regenerative Medicine Market Significant Players

Some of the significant players in the global market for regenerative include Advanced Cell Technology, Baxter International, Inc., Organogenesis, BioMimetic Therapeutics, Cook Biotech, LifeSciences, Medtronic, CryoLife, Stryker and RTI surgical, Osiris Therapeutics, Sanofi, LifeCell Kinetic Concepts, StemCellsInc, to mention a few.

FOR MORE DETAILS - https://www.marketresearchfuture.com/reports/regenerative-medicine-market-2220

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Healthcare Personal Protection Equipment Market Dynamics, Forecast, Analysis And Supply Demand 2027

 

Market Research Future (MRFR) collected data on several factors including implications of covid-19 impact on microbiome sequencing services market and demographic challenges, showed how it could move forward in the coming years.

Global Healthcare Personal Protection Equipment Market is expected to cross USD 10.116 Billion by 2027 at a CAGR of 9.17%.  

Market Synopsis

Personal Protective Equipment (PPEs) are protective gear designed to safeguard the health of workers by minimizing the exposure to a biological agent. It is one of the necessary tools in preventing transmission of infectious diseases not only in treatment centers but also in various activities, e.g. cleaning, waste management and safe burials, and community care related to the outbreak. Components of PPE are goggles, face-shield, mask, gloves, coverall/gowns (with or without aprons), head cover, shoe cover, and others.

Impact of Covid-19 Outbreak on Healthcare Personal Protection Equipment Market

Healthcare Personal Protection Equipment (PPE) are protective gears that are designed to safeguard the workers by minimizing the exposure to a biological agent. PPE helps healthcare workers to fight against novel coronavirus (COVID-19). The World Health Organization (WHO) has recommended several governments worldwide to increase the production of masks, gloves, respirators, and coveralls/gowns. It also recommended that PPE manufacturers must increase their production by 40% and prioritizing their orders to countries with a high demand-supply gap.   

Several countries, including India, have considered importing PPE kits to meet its requirements from China, Singapore, and South Korea. Although a tender was rolled out last week by the government's nodal procurement agency HLL Lifecare, the government has chosen not to wait for the bids to be released, rather than source it from other countries. As of the 3rd week of April, the coronavirus (COVID-19) pandemic crossed two million cases globally. The increasing demand for hand protection, respiratory protection, and protective clothing in the healthcare industry to ensure people’s safety during the ongoing COVID-19 pandemic is expected to boost the demand for PPE.  Furthermore, the increasing government initiatives to facilitate the import of PPE is expected to drive the market growth. For instance, in March 2020, in response to the COVID-19 outbreak, the Food and Drug Administration (FDA) initiated numerous steps to improve the US stocks of PPE. A few of its measures include adjustments in import screening, flexibility to manufacturers, and creation of special mailbox service, among other provisions.

We have observed the massive impact of novel coronavirus on people’s lives over the last five months. It has also impacted various industries across the globe, eventually affecting the global economy. Some industries have experienced negative growth, whereas some industries have experienced tremendous demand and have generated massive revenues in this period. Covid 19 Impact on Healthcare Personal Protection Equipment market is the one of the positive impact sector on global industry

 

Healthcare Personal Protection Equipment Market Influencer

PPE helps healthcare workers to fight against novel coronavirus (COVID-19). The World Health Organization (WHO) has recommended the governments across the world to increase the production of masks, gloves, respirators, and coveralls/gowns. It also recommended that PPE manufacturers must increase their production by 40% and prioritizing their orders to the countries with a high demand-supply gap.

Market Drivers

• As of the 3rd week of April, coronavirus (COVID-19) pandemic crossed 2 million cases globally. The increasing demand for hand protection, respiratory protection, and protective clothing in the healthcare industry to ensure the people’s safety during the ongoing COVID-19 pandemic is expected to boost the demand for Personal Protective Equipment (PPE).

• Rapid technological advancements in the field of surgery such as High-Reliability Organizing (HRO), technical advancements, and standardizing procedures are expected to have a positive impact on the hospital sector, thereby impacting the demand for personal protective equipment positively.

• Increasing government initiatives to facilitate the import of personal protective equipment is expected to drive the market growth. For instance, in March 2020, in response to the COVID-19 outbreak, the Food and Drug Administration (FDA) initiated numerous steps to improve US stocks of personal protective equipment. The measures include adjustments in import screening, flexibility to manufacturers, and creation of special mailbox service, among other provisions.

• The emergence of local PPE manufacturers, increasing end user demand, and the rising production of cost-effective and integrated PPE is expected to boost the market growth. For instance, in India, the Union Textiles Ministry and the Health Ministry has said the government is augmenting the supplies of personal protective equipment (PPEs), including body coveralls, N-95 masks and 2-ply/3-ply surgical masks required for healthcare professionals dealing with COVID-19 cases. Furthermore, more than 130 Australian companies have responded to an urgent call to dramatically boost the manufacturing of face masks, gowns, and gloves to deal with the COVID-19 crisis.

Market Restraints

• The current global stockpile of PPE is inadequate to handle the existing and expected cases in different parts of the world, particularly for medical masks and respirators. The supply of gowns and goggles is also expected to be insufficient as the disease is spread. Surging global demand is not only driven by the increasing number of COVID-19 cases but also by misinformation, hoarding, and panic buying. The lockdown in a significant portion of the world is hampering the manufacturing of PPE.

• The high cost of raw materials (specialized clothing and other related products) is hindering the demand for PPEs in economically weak countries.

Healthcare Personal Protection Equipment Market Segmentation

By Product

• Protective Clothing: The protective clothing is further segmented into coveralls, gowns, and others. Coverall/gowns are designed to protect the torso of healthcare providers from exposure to the virus.

• Respiratory Protection: Respiratory protection is bifurcated into surgical masks, respirator masks, and others. The healthcare professionals are recommended to use surgical N95 respirators or medical respirators to protect them from the direct exposure to the COVID-19 virus.

• Head, Eye, and Face Protection: The largest segment. To prevent exposure of the eye and face from the virus, goggles or a face shield should be considered. High risk of COVID-19 and other infections through nose, eyes, and ears is among the primary reason driving the growth for this segment. The goggles must fit the contours of the user’s face and are compatible with the respirator. The use of face shields/ goggles is an integral part of standard and contact precautions for the people most at risk of COVID-19 infection.

• Protective Footwear: The use of protective footwear such as washable and disposable footwear is essential to avoid self-contamination.

• Hand protection: Hand protection is further sub-segmented into general-purpose, chemical handling, sterile gloves, and surgical. The rising awareness about hygiene and prevention from the transmission of pathogens in healthcare facilities is increasing the demand for medical gloves.

• Others

By End Use

• Hospitals & Clinics: The largest segment and expected to grow at the highest CAGR during the forecast period. The rising awareness regarding the hand protection during a viral outbreak is increasing the demand for PPEs in hospitals.

• Ambulatory Surgical Centers: The increasing number of patients visiting surgical centers is facilitating the demand for PPEs in ambulatory surgical centers.

• Academic and Research Institutes: PPEs are very effective in minimizing occupational injuries, accidents, and other hazards which otherwise result in substantial manpower and financial losses. The use of basic PPE is a must in research institutes as they protect from skin contact and contamination.

• Diagnostic Laboratories: The use of protective equipment is necessary for diagnostic laboratories to protect healthcare workers from specific hazards and hazardous materials.

• Others

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/report/covid-19-impact-healthcare-personal-protection-equipment-market

By Region

• Americas: The largest regional market. The increasing government initiatives and rising concerns in terms of health and safety of healthcare professionals is boosting the demand for the same. Moreover, the rising prevalence of COVID-19 infection is majorly contributing to the growth of this region.

• Europe: The healthcare market in Northern European economies, such as Germany, U.K., and Sweden, is expected to exhibit an increase in healthcare expenditure, thereby leading to the growth in production as well as the consumption of medical devices and products.

• Asia-Pacific: The fastest-growing regional market. Emerging market players in the region, technological advancements, rising focus of government towards healthcare facilities, and high target population in the region are among the key factors driving the market growth in the region.   

• Middle East & Africa: The high penetration of personal protective equipment in developed healthcare industries of UAE, South Africa is expected to drive the growth of the market in this region.

 

Particle Counter Market - Demand, Growth, Opportunities And Analysis Of Top Key Player Forecast To 2025

 Market Forecast

Global Particle Counter Market size is expected to cross USD 168.2 Million by 2025 at a CAGR of 7.1% during the forecast period of 2019 to 2025.

Market Synopsis

A particle counter is a tool for monitoring indoor air quality to understand the concentration of particles in the air in cleanrooms and workplaces. This device would not identify specifically what kinds of dust particulates are present in the air, but it will identify how many airborne particles of a certain size are present in the environment.

The growing pharmaceutical sector along with stringent regulatory policies are driving the particle counter market growth. Additionally, increasing numbers of growth strategies adopted by major players are further driving the market growth globally. For instance, in June 2019, TSI launched the AeroTrak+ Remote Airborne Particle Counters for monitoring manufacturing cleanrooms.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/8776 

Market Influencer

Rising production by the pharmaceutical industry and stringent regulations are likely to impact the growth of the particle counter industry positively.

Market Drivers

• The growing pharmaceutical industry will support the growth of the particle counter market during the forecast period.

• Rising research & development in the pharmaceutical and biotechnology industry to cater to rising needs for treatments of various chronic diseases is driving the growth of the particle counter market. For instance, according to a recent survey, the pharmaceutical and biotechnology industry in the US spent a total of USD 102 billion on research & development in 2015. Additionally, according to the National Institute for Health Research, the Association of the British Pharmaceutical Industry (ABPI) invested over USD 4.46 billion just in the UK on R&D, looking for breakthroughs for conditions such as cancer, dementia, and rare genetic diseases.

• Stringent government regulations regarding the quality of air in the pharmaceutical and medical device industry.

• Rising product launches and product advancements by major market players.

Market Restraints

• The high cost of particle counters and technical limitations of particle counters is hampering the growth of the global particle counter market.

Particle Counter Market Segmentation

By Product Type

• Airborne Particle Counters: Airborne particle counters are widely used to monitor signs of cleanroom air contamination, and, in most cases, the particle count data is used to make critical process decisions regarding cleanroom certifications. These airborne particle counters, work on a light scattering principle. They utilize a very bright light source to illuminate the particles.

• Liquid Particle Counters: Liquid particle counting is used to measure the size and distribution of particles in a liquid or on solid samples. This particle counter works by irradiating a liquid sample with a laser diode and detecting the scattered light. The properties of the scattered light are related to the particle size. The particle size is then measured, and the number of particles present in each size range is determined. Aviation & space exploration, heavy machinery, and automobile manufacturing are the fields where particle control in hydraulic systems plays an important role.

By Technology

• Online Particle Counters: Online/Inline measuring systems are designed to mount directly to stationary systems for continuous or periodic monitoring or can be used as mobile monitoring solutions in hydraulic and lubricating systems.

• Offline Particle Counters: Offline particle counters use mineral as the operating fluid, and their portable size makes them most suitable for on-site applications. These particle counters are widely used for automatically measuring & displaying particulate contamination, moisture & temperature levels in various hydraulic fluids.

By Modularity

• Portable Particle Counters: The portable particle counter holds the majority share in the modularity segment attributing to the high adoption rate of these systems across the globe. Portable particle counters are easy to handle and are designed to save time and money. Demand for portable particle counters is rapidly growing in aerospace, automotive, pharmaceutical, oil & gas, and food & beverage industries.

• Remote Particle Counters: Remote Particle counters are perfect for monitoring large cleanrooms or critical environments. Their small size, flexible power options, and wireless capabilities make them a preferred option for large clean rooms.

• Handheld Particle Counters: These particle counters being lightweight and easy to carry, well-suited for cost-effective spot-checking. They are ideal for checking sources of contamination and perform indoor air quality (IAQ) investigations for consistently meeting the air quality parameters.

By End-User

• Medical Device Industry: In 2018, the medical device industry held the largest share in the market due to increased R&D expenditure and the establishment of new manufacturing facilities by global pharmaceutical giants in newer geographies. Additionally, increasing infections arising due to contaminated devices and the implementation of stringent regulations to maintain air quality is driving the market growth.

• Pharmaceutical Industry: Pharmaceutical industry accounted for the second-largest market share due to the growing volume of compounds to be detected for the presence of impurities in pharmaceutical samples and stringent safety regulations. Effective sterilization processes are vital within the pharmaceutical industries, and the safety of process units and final products depends on the highest quality of hygienic practice, as well as strict controls and regulatory compliance. Air quality rules and regulations need to be complied to ensure that the product remains sterile. This leads to a rise in the particle counter market as pharmaceutical firms are emphasizing on the use of particle counter methods to ensure air quality.

• Research Laboratories: Particle countering is a key factor of air quality monitoring in laboratories where products or processes are sensitive to environmental contamination.

• Others: Others include hospitals, specialty centers, diagnostic centers.

By Region

• Americas: The Americas held the largest regional market share in 2018. This is owing to the high adoption rate of particle counters and stringent regulations by the FDA. Additionally, product launches and product advancements by major market players are driving the growth in the Americas region.

For instance, in February 2018, Particle Plus launched Particles Plus 2000 series in four size channels—0.3, 0.5, 1.0, and 5.0 µm.

• Europe: The need for particle counter is high in this region due to growth in the pharmaceutical and medical device industry. Additionally, increasing support from governments, the presence of a huge geriatric population, and rising healthcare spending are driving the market growth.

• Asia-Pacific: The Asia-Pacific region accounted for the third-largest market share due to presence of a large number of research organizations, low manufacturing cost and labor cost, developing healthcare infrastructure, and increased investments by the American and European market giants in Asian countries such as China and India

• Middle East & Africa: It is estimated to account for the least share of the global particle counter market due to the limited development of healthcare facilities.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/particle-counter-market-8776   

Whole Exome Sequencing Market Value Share, Supply Demand, Share And Value Chain 2020

 Market Overview

Global Whole Exome Sequencing Market size is expected to register a CAGR of 19.80% to reach USD 2,696.03 Million by 2025.

Synopsis

Whole exome sequencing is a widely used next-generation sequencing (NGS) method to determine the nucleotide sequence primarily of the protein-coding regions of an individuals related sequences, representing approximately 1% of the complete DNA sequence. The human exome represents less than 2% of the genome but contains ~85% of known disease-related variants. This is the key reason for the usage of exome in the identification and the determination of genetic variants causing various diseases such as Miller syndrome and Alzheimer’s.

Factors that drive the market growth are the decreasing cost of sequencing, the use of whole-exome sequencing technology for varied applications, and strategic alliances amongst key players & research institutes. However, the lack of skilled professionals and ethical & legal issues related to whole-exome sequencing are hampering the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8763 

Market Dynamics

Market players operating in the global whole exome sequencing market are focusing on product launches, approvals, and partnerships to gain market dominance and keep their product updated and in demand. For instance, in November 2019, NantHealth, Inc. (US), a next-generation, personalized healthcare company, received FDA authorization of Omics CoreSM, the first whole-exome sequencer used to analyze both tumor and somatic gene to measure overall tumor mutational burden (TMB) in cancer tissue.

Segmentation

Global Whole Exome Sequencing Market has been segmented on the basis of Product, Technology, Application, and End User. The market, based on product, has been segmented into kits, sequencer, and services. Kits are further segmented into DNA Fragmentation, End Repair, A-Tailing, And Size Selection Kits, Library Preparation, and Target Enrichment. Services are further sub-segmented into Sequencing Services, Data Analysis (Bioinformatics), and Others. The global whole exome sequencing market, by technology, has been categorized as Sequencing by Synthesis (SBS), ION Semiconductor Sequencing, and others. The market by application is segmented into diagnostics, drug discovery, and development, agriculture and animal research, others. Based on end user, the market is segmented into research centers and government institutes, hospitals and diagnostics centers, pharmaceutical & biotechnology companies, and others.

Regional Analysis

The Americas was the largest market for whole exome sequencing in 2019. The growth of the Americas market is due to the high prevalence rate of cancer and other chronic disorders and rising healthcare expenditure. Additionally, favorable initiatives by the government and other organizations for the development and adoption of whole-exome sequencing technologies are driving the market for whole-exome sequencing. For instance, in 2018, All of Us Research Program, a part of the National Institutes of Health, awarded funds over USD 28.6 million to establish three genome centers in the US. These centers aim to produce genome data for researchers and the program’s precision medicine research platform, a national resource to support studies on a variety of important health questions.

Europe is the second-largest market for whole exome sequencing with Western Europe, holding the largest market share. The European market is expected to register a sturdy growth rate during the forecast period due to rising cases of cancer and increasing programs for the adoption of genome sequencing. According to the International Agency for Research on Cancer, in 2018, there were about 4,229,662 cases of cancer in Europe. This huge cases of cancer and rising genome mapping programs are expected to have a positive impact on the growth of the whole-exome sequencing market.

Asia-Pacific is expected to represent the highest market growth potential over the forecast period due to the growing patient pool and increasing technological advancements. The fast growth of the Asia-Pacific region is due to the increasing per capita income along with government initiatives to enhance the quality of healthcare. China, India, and Australia have a lucrative market for Whole Exome Sequencing due to the growing older population. Moreover, according to the report published by the United Nations in 2015, the number of older people aged 60 years or above in the world is predicted to grow by 56% between 2015 and 2030. 66% of the older population out of the total global population would also reside in the Asia-Pacific region.

In the Middle East & Africa, the whole exome sequencing market accounts for significant market share. Countries such as Kuwait, the UAE, and Saudi Arabia are likely to show steady growth due to increasing cancer cases, rising initiatives by governments to improve patient care, and favorable reimbursement policies. However, the rest of the Middle East and Africa might show an inactive growth due to affordability and accessibility issues.

Key Players

The Prominent Players in the Global Whole Exome Sequencing Market are Illumina Inc. (US), BGI (China), Eurofins Scientific (Belgium), Thermo Fisher Scientific (US), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), GENEWIZ (US), Ambry Genetics (US), Macrogen, Inc. (South Korea), Integragen SA (France), and others.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/whole-exome-sequencing-market-8763